Bull and Bear

Bull and Bear

Verdict: Lean Long, Wait For Confirmation — the platform evidence (36% CIR, 27% RoTCE held across two prior integrations, CEO open-market buy at €147.50 three weeks ago) is real, but the bear's forensic case that FY24–25 earnings carry ~€240M of low-quality income is also documented and the cushion that produced it is gone. The decisive data lands inside the next four months: H1 FY2026 prints in early August 2026 reveal whether underlying risk costs and CIR are converging back to platform levels or whether the FY24 flatter has reversed into a forward earnings hole. Bull wins more weight because the operating gap predates the rate cycle and management has bought, not sold, into the re-rate; but the gap between 16bps (FY24 risk costs) and 46bps (Q1 2026) is a real reset that compresses the EPS denominator before any PTSB execution risk shows up. The single tension that decides this is whether 27% RoTCE is the run-rate or the peak — and that question is answerable on a published date, not in the abstract. Buy the platform when the H1 print confirms it; pay 3x book on faith only if you accept asymmetric downside to ~€100.

Bull Case

Bull's price target is €195 in 12-18 months, derived as 3.4x P/TBV on a rolled-forward FY2027 tangible book of ~€57/share, cross-checked at FY27 EPS ~€13 × 15x P/E. The primary catalyst is PTSB closing in Q3 2026 with the first integrated quarter (Q4 2026 / Q1 2027) showing group RoTCE held above 25%. The disconfirming signal is a Q4 2026 or Q1 2027 print where RoTCE drops below 22% and CIR rises above 38% on a clean ex-PTSB-one-offs basis — both metrics breaking together would invalidate the platform thesis.

Bear Case

Bear's downside target is €100 (-31% from €145.50) in 12-18 months: strip ~€100M overlay flatter and ~€92M Day-1 gains from run-rate net profit → EPS ~€9.20; apply 11x P/E (the 2019-2023 regime multiple at lower RoTCE) → ~€100. The primary trigger is FY26 H1 results in early August 2026 showing risk costs above 45bps and CIR failing to converge below 35% — confirms the FY24 flatter has reversed into a forward earnings hole. The cover signal is FY26 H1 risk costs under 35bps with CIR below 34% and PTSB closing-period commentary disclosing Irish mortgage NIMs flat-to-expanding versus FY25 entry assumptions.

The Real Debate

Verdict

Lean Long, Wait For Confirmation. Bull carries more weight because the 36% cost-income ratio and the 14-of-14 self-funded acquisition record predate the rate cycle, the CEO bought €1.19M at €147.50 three weeks before this report, and the bear's earnings haircut still leaves a high-teens-RoTCE bank trading at a market multiple — not a value trap. The decisive tension is whether 27% RoTCE is the platform run-rate or the FY24 peak: H1 FY2026 results in early August 2026 publish risk costs and standalone CIR that answer the question on a known date, before the PTSB integration window dominates the print. The bear could still be right because the ECL overlay buffer is empty, Q1 2026 risk costs already stepped to 46bps, the rising-DPS streak breaks in 2026, and 2.99x P/TBV is one standard deviation above its prior regime — a peak-cycle multiple and a peak-cycle earnings number arriving simultaneously is precisely how value traps form. The verdict shifts to outright Lean Long if H1 FY26 prints risk costs under 40bps with standalone CIR below 36% and PTSB closing-period commentary discloses Irish mortgage NIMs flat or expanding versus entry; it shifts to Avoid if H1 risk costs exceed 45bps with CIR above 36% on a clean basis, or if PTSB closing slips past Q3 2026. Pay the 3x book multiple after the platform is reconfirmed in print, not in advance of it.